Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 18,569 shares of the firm’s stock in a transaction on Tuesday, December 12th. The stock was acquired at an average price of $5.84 per share, for a total transaction of $108,442.96. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Monday, December 4th, Levin Capital Strategies, L.P. acquired 8,409 shares of Fluidigm stock. The shares were purchased at an average price of $5.48 per share, for a total transaction of $46,081.32.
  • On Wednesday, November 29th, Levin Capital Strategies, L.P. acquired 20,380 shares of Fluidigm stock. The shares were purchased at an average price of $5.71 per share, for a total transaction of $116,369.80.
  • On Friday, November 17th, Levin Capital Strategies, L.P. acquired 6,880 shares of Fluidigm stock. The shares were purchased at an average price of $5.05 per share, for a total transaction of $34,744.00.
  • On Wednesday, November 8th, Levin Capital Strategies, L.P. acquired 54,900 shares of Fluidigm stock. The shares were purchased at an average price of $5.26 per share, for a total transaction of $288,774.00.
  • On Wednesday, October 25th, Levin Capital Strategies, L.P. acquired 4,227 shares of Fluidigm stock. The shares were purchased at an average price of $5.42 per share, for a total transaction of $22,910.34.
  • On Monday, October 23rd, Levin Capital Strategies, L.P. acquired 22,363 shares of Fluidigm stock. The shares were purchased at an average price of $5.47 per share, for a total transaction of $122,325.61.
  • On Thursday, October 19th, Levin Capital Strategies, L.P. acquired 60,000 shares of Fluidigm stock. The shares were purchased at an average price of $4.55 per share, for a total transaction of $273,000.00.
  • On Tuesday, October 17th, Levin Capital Strategies, L.P. acquired 144,200 shares of Fluidigm stock. The shares were purchased at an average price of $4.59 per share, for a total transaction of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. acquired 50,000 shares of Fluidigm stock. The shares were purchased at an average price of $4.59 per share, for a total transaction of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. acquired 95,843 shares of Fluidigm stock. The shares were purchased at an average price of $4.57 per share, for a total transaction of $438,002.51.

Shares of Fluidigm Co. (NASDAQ:FLDM) traded up $0.05 during mid-day trading on Wednesday, hitting $5.82. 58,189 shares of the stock traded hands, compared to its average volume of 253,310. Fluidigm Co. has a 12-month low of $2.52 and a 12-month high of $8.69. The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.46 and a current ratio of 3.02.

Separately, ValuEngine upgraded shares of Fluidigm from a “strong sell” rating to a “sell” rating in a research report on Monday, October 23rd.

Several hedge funds have recently made changes to their positions in the company. Virtu KCG Holdings LLC purchased a new position in Fluidigm during the second quarter valued at $105,000. Sei Investments Co. grew its stake in Fluidigm by 221.7% during the third quarter. Sei Investments Co. now owns 21,668 shares of the medical research company’s stock valued at $109,000 after acquiring an additional 14,932 shares in the last quarter. PDT Partners LLC grew its stake in Fluidigm by 56.0% during the second quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock valued at $110,000 after acquiring an additional 9,800 shares in the last quarter. Group One Trading L.P. grew its stake in Fluidigm by 336.9% during the third quarter. Group One Trading L.P. now owns 23,155 shares of the medical research company’s stock valued at $117,000 after acquiring an additional 17,855 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Fluidigm during the third quarter valued at $123,000. Hedge funds and other institutional investors own 93.33% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.americanbankingnews.com/2017/12/13/fluidigm-co-fldm-insider-buys-108442-96-in-stock.html.

About Fluidigm

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.